Old Web
English
Sign In
Acemap
>
Paper
>
A phase II study of the gamma-secretase inhibitor avagacestat (BMS-708163) in predementia Alzheimer's disease
A phase II study of the gamma-secretase inhibitor avagacestat (BMS-708163) in predementia Alzheimer's disease
2013
Vlad Coric
Stephen Salloway
Christopher H. van Dyck
Wendy Kerselaers
Stephen Kaplita
Craig Curtis
Joel Ross
Ralph W. Richter
Niels Andreasen
Mark Brody
Sanjiv K. Sharma
Jesse Cedarbaum
Robert M. Berman
Keywords:
Gamma secretase
Phases of clinical research
Diabetes mellitus
Avagacestat
Disease
Psychiatry
Psychology
Pharmacology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
9
Citations
NaN
KQI
[]